Cite
MLA Citation
Helena Edlund et al.. “Exposure–response analysis of acalabrutinib and its active metabolite, ACP‐5862, in patients with B‐cell malignancies.” British journal of clinical pharmacology, vol. 88, no. 5, 2022, pp. 2284–2296. http://access.bl.uk/ark:/81055/vdc_100153442678.0x000022